Integrated DNA Technologies expands global sales network
Company now selling directly to customers in South Korea
Integrated DNA Technologies (“IDT”) acquired MBiotech, Inc. (“MBiotech”), headquartered in Seoul, South Korea. MBiotech has been a distributor of IDT products for more than a decade.
In its promotion of IDT products, MBiotech has successfully made IDT’s brand well-known throughout South Korea. The company also distributes products for other manufacturers. These other products include reagents, enzymes, kits, consumables and lab equipment. Moving forward, IDT will continue MBiotech’s distribution activities of other manufacturers’ products and plans to keep day-to-day operations unchanged.
Dr Joseph A. Walder, IDT founder and chief executive officer, commented, “IDT has enjoyed a long-standing relationship with MBiotech. We respect and welcome them into the company. MBiotech’s local-language website, efficient operations, and extensive distributor base make it a valuable asset.”
Joshua Lee, founder, president and CEO of MBiotech said, “We share IDT’s commitment to excellent customer service and quality. We are very pleased to become part of the IDT family. As one company, we will be able to offer better service to our Korean customers and those in our global markets.”
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Algeta signs €560 million global agreement with Bayer for development and commercialization of Alpharadin for bone metastases
QIAGEN Expands Partnership with Genome Diagnostics for Development of Tests in Prevention and Personalized Healthcare - Extended HLA testing portfolio includes products to assess tolerance for Lumiracoxib and for the early detection of inflammatory diseases
Compound created at OSU could become important new antidepressant
The 2011 Körber Prize goes to Stefan Hell - With a groundbreaking idea the physicist has overcome the diffraction resolution barrier in optical microscopy
University of Maryland researchers identify gene variant linked to effectiveness of plavix - First study to use genome-wide scanning approach to locate gene that affects response to popular anti-clotting medication
Axon to Supply Scanners for Affymetrix High-Throughput GeneChip(R) Platform
Löfgren_syndrome
Category:Sulfur_metabolism
Mechanism for potential Friedreich's ataxia drug uncovered - Discovery takes researchers one step closer to human clinical trials and could improve understanding of other diseases
Researchers Imitate Molecular Crowding in Cells
